Literature DB >> 10851091

Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle.

M Thullberg1, J Bartek, J Lukas.   

Abstract

Assembly and activity of the proto-oncogenic cyclin D/CDK4(6) complexes, the major driving force of G1 phase progression, is negatively regulated by a family of INK4 CDK inhibitors p16INK4a, p15INK4b, p18INK4c, and p19INK4d. Expression of the INK4 family members is controlled at the transcriptional level, through differential response to environmental and intracellular signals such as cytokines, oncogenic overload, or cellular senescence. Here we show that the periodic oscillation of the p19INK4d protein during the cell cycle is determined by the ubiquitin/proteasome-dependent mechanism, allowing the protein abundance to follow the changes in its mRNA expression. Within the INK4 family, this regulatory mode appears restricted to p19INK4d whose ubiquitination was dependent on the integrity of lysine 62, and binding to CDK4. These results highlight unexpected differences among the INK4 inhibitors, and suggest how p19INK4d may help regulate the rate of cyclin D/CDK4(6) complex formation, and thereby timely progression through the mammalian cell division cycle. Oncogene (2000) 19, 2870 - 2876

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851091     DOI: 10.1038/sj.onc.1203579

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.

Authors:  Feng Bai; Ho Lam Chan; Matthew D Smith; Hiroaki Kiyokawa; Xin-Hai Pei
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

2.  p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Authors:  Anna Felisiak-Golabek; Agnieszka Dansonka-Mieszkowska; Iwona K Rzepecka; Lukasz Szafron; Ewa Kwiatkowska; Bozena Konopka; Agnieszka Podgorska; Alina Rembiszewska; Jolanta Kupryjanczyk
Journal:  Cancer Biol Ther       Date:  2013-08-14       Impact factor: 4.742

3.  Oncogenic H-Ras V12 promotes anchorage-independent cytokinesis in human fibroblasts.

Authors:  Minna Thullberg; Annica Gad; Sylvie Le Guyader; Staffan Strömblad
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

4.  Ubiquitin not only serves as a tag but also assists degradation by inducing protein unfolding.

Authors:  Tzachi Hagai; Yaakov Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

5.  The expression pattern of the cell cycle inhibitor p19(INK4d) by progenitor cells of the rat embryonic telencephalon and neonatal anterior subventricular zone.

Authors:  V Coskun; M B Luskin
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

6.  Phosphorylation-induced unfolding regulates p19INK4d during the human cell cycle.

Authors:  Amit Kumar; Mohanraj Gopalswamy; Annika Wolf; David J Brockwell; Mechthild Hatzfeld; Jochen Balbach
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

7.  Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

Authors:  Sladjana Gagrica; Sharon Brookes; Emma Anderton; Janice Rowe; Gordon Peters
Journal:  Cancer Res       Date:  2011-11-11       Impact factor: 12.701

8.  Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies.

Authors:  Serhiy Pankiv; Trond Lamark; Jack-Ansgar Bruun; Aud Øvervatn; Geir Bjørkøy; Terje Johansen
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

9.  Biological regulation via ankyrin repeat folding.

Authors:  Doug Barrick
Journal:  ACS Chem Biol       Date:  2009-01-16       Impact factor: 5.100

10.  Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.

Authors:  Antoine Forget; Olivier Ayrault; Willem den Besten; Mei-Ling Kuo; Charles J Sherr; Martine F Roussel
Journal:  Cell Cycle       Date:  2008-12-13       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.